nitroglycerin has been researched along with Dyslipidemia in 4 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rabbits with dyslipidemia were produced and randomly assigned into untreated, atorvastatin, nitroglycerin and combined groups (n=10 in each group)." | 7.83 | Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia. ( Cui, L; Li, F; Wang, J; Yang, F, 2016) |
| "Rabbits with dyslipidemia were produced and randomly assigned into untreated, atorvastatin, nitroglycerin and combined groups (n=10 in each group)." | 3.83 | Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia. ( Cui, L; Li, F; Wang, J; Yang, F, 2016) |
| "Treatment with fenofibrate significantly improved arterial endothelial function after 4 months." | 2.80 | Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy. ( Celermajer, DS; Harmer, JA; Keech, AC; Marwick, TH; Meredith, IT; Skilton, MR; Veillard, AS; Watts, GF, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harmer, JA | 1 |
| Keech, AC | 1 |
| Veillard, AS | 1 |
| Skilton, MR | 1 |
| Marwick, TH | 1 |
| Watts, GF | 2 |
| Meredith, IT | 1 |
| Celermajer, DS | 1 |
| Yang, F | 1 |
| Wang, J | 1 |
| Li, F | 1 |
| Cui, L | 1 |
| Chan, DC | 1 |
| Wong, AT | 1 |
| Yamashita, S | 1 |
| Lopes, FG | 1 |
| Bottino, DA | 1 |
| Oliveira, FJ | 1 |
| Mecenas, AS | 1 |
| Clapauch, R | 1 |
| Bouskela, E | 1 |
2 trials available for nitroglycerin and Dyslipidemia
| Article | Year |
|---|---|
Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
Topics: Aged; Australia; Brachial Artery; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; End | 2015 |
Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
Topics: Adult; Aged; Analysis of Variance; Apolipoprotein B-48; Apolipoprotein C-III; Brachial Artery; Chole | 2012 |
2 other studies available for nitroglycerin and Dyslipidemia
| Article | Year |
|---|---|
Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia.
Topics: Animals; Atorvastatin; Disease Models, Animal; Drug Therapy, Combination; Dyslipidemias; Hydroxymeth | 2016 |
In elderly women moderate hypercholesterolemia is associated to endothelial and microcirculatory impairments.
Topics: Adult; Age Factors; Aged; Anthropometry; Blood Flow Velocity; Cholesterol; Cholesterol, LDL; Dyslipi | 2013 |